Health Condition 1: K859- Acute pancreatitis, unspecified
Conditions
Interventions
Intervention1: paracetamol: paracetamol I.V 1000mg/100ml Normal Saline three times a day for 7 days
Control Intervention1: tramadol: tramadol I.V 50mg/100 ml Normal Saline three times a day for 7day
Sponsors
DR ABHIJEET SHRIDHAR
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of age 18 or more, with diagnosis of Acute Pancreatitis, Irrespective of severity 2. Acute pancreatitis will be diagnosed according to revised Atlanta Classification 2012, which require 2 or more of the following criteria be met for the diagnosis; (a) Abdominal pain suggestive of pancreatitis (b) Serum amylase or lipase level greater than three times the upper normal value (c) Characteristic imaging findings
Exclusion criteria
Exclusion criteria: 1. Patients with severe hepatic impairment & severe renal impairment (Creatinine clearance less than 30mL/min) 2. Ongoing treatments with NSAIDs (within 24hrs) 3. History of allergy to paracetamol and/or tramadol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To Determine the effectiveness of Intravenous Paracetamol and Intravenous Tramadol in treating pain. 2. To Compare. pain alleviation between Paracetamol and Tramadol 3. Analyzing patient-reported pain intensity outcomes 4. Potentially assessing adverse events or adverse drug reactions with Paracetamol and Tramadol Timepoint: 18-24 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The duration of pain alleviation provided by Tramadol & Paracetamol 2. Assessing the impact of these medications on hospital stays or re-admission rates 3. Examining overall patient satisfaction with pain management Timepoint: 18-24 months | — |
Countries
India
Contacts
Public ContactDR JAMEEL AHMAD
Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University
Outcome results
None listed